These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12409590)

  • 1. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.
    Huo Z; Giger ML; Olopade OI; Wolverton DE; Weber BL; Metz CE; Zhong W; Cummings SA
    Radiology; 2002 Nov; 225(2):519-26. PubMed ID: 12409590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms.
    Li H; Giger ML; Olopade OI; Margolis A; Lan L; Chinander MR
    Acad Radiol; 2005 Jul; 12(7):863-73. PubMed ID: 16039540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.
    Li H; Giger ML; Olopade OI; Chinander MR
    J Digit Imaging; 2008 Jun; 21(2):145-52. PubMed ID: 18175183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location.
    Li H; Giger ML; Huo Z; Olopade OI; Lan L; Weber BL; Bonta I
    Med Phys; 2004 Mar; 31(3):549-55. PubMed ID: 15070253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized analysis of mammographic parenchymal patterns on a large clinical dataset of full-field digital mammograms: robustness study with two high-risk datasets.
    Li H; Giger ML; Lan L; Bancroft Brown J; MacMahon A; Mussman M; Olopade OI; Sennett C
    J Digit Imaging; 2012 Oct; 25(5):591-8. PubMed ID: 22246204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study.
    Gierach GL; Li H; Loud JT; Greene MH; Chow CK; Lan L; Prindiville SA; Eng-Wong J; Soballe PW; Giambartolomei C; Mai PL; Galbo CE; Nichols K; Calzone KA; Olopade OI; Gail MH; Giger ML
    Breast Cancer Res; 2014; 16(4):424. PubMed ID: 25159706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection.
    Huo Z; Giger ML; Wolverton DE; Zhong W; Cumming S; Olopade OI
    Med Phys; 2000 Jan; 27(1):4-12. PubMed ID: 10659732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.
    Gilbert FJ; Warren RM; Kwan-Lim G; Thompson DJ; Eeles RA; Evans DG; Leach MO;
    Radiology; 2009 Aug; 252(2):358-68. PubMed ID: 19703879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
    Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
    Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
    BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment.
    Li H; Giger ML; Olopade OI; Lan L
    Acad Radiol; 2007 May; 14(5):513-21. PubMed ID: 17434064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Mitchell G; Antoniou AC; Warren R; Peock S; Brown J; Davies R; Mattison J; Cook M; Warsi I; Evans DG; Eccles D; Douglas F; Paterson J; Hodgson S; Izatt L; Cole T; Burgess L; Eeles R; Easton DF
    Cancer Res; 2006 Feb; 66(3):1866-72. PubMed ID: 16452249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.
    Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
    van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
    Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
    Yao L; Sun J; Zhang J; He Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Breast Cancer Res Treat; 2016 Apr; 156(3):441-445. PubMed ID: 27033093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
    Larouche G; Chiquette J; Pelletier S; Simard J; Dorval M
    Fam Cancer; 2017 Jan; 16(1):35-40. PubMed ID: 27554086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.